So at the end of the 30 june 2018 mesoblast had $77.763million*
*includes $40m from Novaquest paid July 10, 2018
Other funds to come
+ $40m from closing of Tasly alliance
+ Royalties from Temcell
+ Government R&D tax incentives
Other loan facilities if required
+ $15m from Hercules accessible before Q4, 2018
+$25m from Hercules accessible before Q3, 2019
+$10m from Novaquest on marketing approval of remestemcel
+ Access from Kentgrove of upto $90m from 2016 facility available within next 12 months.
All in all currently there is $77m + another US$190m available.
*have to check kentgrove facility, correct me if im wrong
Ann: Appendix 4C - quarterly, page-4
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |